Abvc biopharma regains compliance with nasdaq's minimum bid price requirement

Fremont, ca, aug. 10, 2023 (globe newswire) -- via newmediawire -- abvc biopharma, inc. (nasdaq: abvc) ("company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that on august 08, 2023, it received a letter from the nasdaq listing qualifications department notifying the company that it had regained compliance with the minimum bid price requirement.
ABVC Ratings Summary
ABVC Quant Ranking